About
Small Molecules, Biologics, Devices
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalMedical Measurement
Clinical Trials (52)
View allTotal Trials
52
As Lead Sponsor
46
As Collaborator
6
Total Enrollment
16,514
By Phase
PHASE1: 17NA: 2PHASE3: 9PHASE1/PHASE2: 1PHASE2: 3PHASE4: 11PHASE2/PHASE3: 1
By Status
COMPLETED: 45TERMINATED: 3NOT_YET_RECRUITING: 2RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline52 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07102719Lead Sponsor
Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers
PHASE1Not yet recruiting
40 participants
Started: Sep 30, 2025 · Completed: Oct 31, 2025
NCT07151118Collaborator
ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer
N/ANot yet recruiting
100 participants
Started: Sep 1, 2025 · Completed: Aug 31, 2027
NCT06889350Lead Sponsor
Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers
PHASE1Completed
40 participants
Started: Mar 26, 2025 · Completed: May 7, 2025
NCT06627322Collaborator
A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)
NARecruiting
5,950 participants
Started: Nov 21, 2024 · Completed: Sep 30, 2029
NCT06339788Lead Sponsor
Pharmacokinetics of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers
PHASE1Completed
40 participants
Started: May 10, 2024 · Completed: Jun 12, 2024
Locations (1)
Headquarters
Seoul, Korea
Map
Loading map...